3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Recruiting
2
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
10
Neoplasms
5
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Prostatic Neoplasms
2
Lung Neoplasms
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Skin Carcinoma
1
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Peripheral Arterial Disease
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Pain
1
Opioid-Related Disorders
1
Nausea
1
Multiple Myeloma
1
Mouth Neoplasms
1
Motor Activity
1
Melanoma
1
Medication Adherence
1
Malignant Solid Neoplasm
1
Lymphoma, Follicular
1
Localised Prostate Cancer
1
Laryngeal Neoplasms
1
Ischemia
1
Hypertension
1
Hemianopsia
1
Interventions
Nivolumab
6
pembrolizumab
3
Specimen Handling
3
Ipilimumab
3
relatlimab
2
cemiplimab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
vedolizumab
1
trametinib
1
toripalimab
1
sulforaphane
1
gadopiclenol
1
famitinib
1
anlotinib
1
X-Rays
1
Watchful Waiting
1
Ultraviolet Therapy
1
Toll-Like Receptor 1
1
Therapeutics
1
Temozolomide
1
Technetium
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
SHR-1701
1
Rehabilitation
1
Phototherapy
1
Photopheresis
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Melanoma
×
Standard of Care
×
Clear all
NCT06470880
2024-06-24
DyNAMIc
The Christie NHS Foundation Trust
Phase 2
Not yet recruiting
40 enrolled